Regeneron Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 3,615 | 0.0% | 4,683 | 12/31/2025 |
| 2025 Q3 | 11/12/2025 | 3,089 | 0.0% | 5,494 | 9/30/2025 |
| 2025 Q2 | 8/12/2025 | 2,250 | 0.0% | 4,286 | 6/30/2025 |
| 2025 Q1 | 5/13/2025 | 3,405 | 0.0% | 5,368 | 3/31/2025 |
| 2024 Q4 | 2/6/2025 | 3,296 | 0.0% | 4,627 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 3,833 | 0.0% | 3,646 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 3,665 | 0.0% | 3,487 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 2,779 | 0.0% | 2,887 | 3/31/2024 |
| 2023 Q4 | 2/12/2024 | 2,471 | 0.0% | 2,813 | 12/31/2023 |
| 2023 Q3 | 11/13/2023 | 2,380 | 0.0% | 2,892 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 1,744 | 0.0% | 2,427 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 2,228 | 0.0% | 2,712 | 3/31/2023 |
| 2022 Q4 | 2/15/2023 | 1,594 | 0.0% | 2,209 | 12/31/2022 |
| 2022 Q3 | 11/10/2022 | 1,869 | 0.0% | 2,713 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 1,682 | 0.0% | 2,845 | 6/30/2022 |
| 2022 Q1 | 5/2/2022 | 2,623 | 0.0% | 3,756 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 2,339 | 0.0% | 3,703 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 1,954 | 0.0% | 3,228 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 1,769 | 0.0% | 3,168 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 2,316 | 0.0% | 4,894 | 3/31/2021 |
| 2020 Q4 | 2/11/2021 | 1,717 | 0.0% | 3,555 | 12/31/2020 |
| 2020 Q3 | 10/30/2020 | 1,610 | 0.0% | 2,877 | 9/30/2020 |
| 2020 Q2 | 8/6/2020 | 723 | 0.0% | 1,160 | 6/30/2020 |
| 2020 Q1 | 4/29/2020 | 487 | 0.0% | 998 | 3/31/2020 |
| 2019 Q4 | 1/17/2020 | 293 | 0.0% | 782 | 12/31/2019 |